Lessons from translational research in EORTC glioma trials von Hegi, M.E

Volltext

SP-0534: New molecular markers for prediction and prognosis ñ ready for personalised therapy? von Hegi, M.E

Volltext

343: Deciphering the role of ubiquitin specific peptidase 15 (USP15) in human glioblastoma von Oikonomaki, M, Hegi, M.E

Volltext

103 - Lessons from translational research in EORTC glioma trials von Hegi, M.E.

Volltext

SP-38: The Rational for Concomitant Radio- and Chemotherapy in Malignant Glioma. State of the Art and Future Perspectives von Stupp, R, Homiscko, K, Mirimanoff, R.O, Negretti, L, Hottinger, A.F, Levivier, M, Hegi, M.E

Volltext

WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1 von Vassallo, I, Zinn, P, Lai, M, Rajakannu, P, Hamou, M-F, Hegi, M E

Volltext

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial von Gao, Y., Weenink, B., van den Bent, M.J., Erdem-Eraslan, L., Kros, J.M., Sillevis Smitt, PAE, Hoang-Xuan, K., Brandes, A.A., Vos, M., Dhermain, F., Enting, R., Ryan, G.F., Chinot, O., Ben Hassel, M., van Linde, M.E., Mason, W.P., Gijtenbeek, J.M.M., Balana, C., von Deimling, A., Gorlia, Th, Stupp, R., Hegi, M.E., Baumert, B.G., French, P.J.

Volltext

Tumor Treating Fields (TTFields)—A Novel Cancer Treatment Modality: Translating Preclinical Evidence and Engineering Into a Survival Benefit with Delayed Decline in Quality of Life... von Stupp, R., Taphoorn, M., Driven, L., Taillibert, S., Honnorat, J., Chen, T.C., Sroubek, J., Paek, S.H., Escuder, J.B., Easaw, J., David, C., Kim, C., Desai, R., Olivi, A., Kew, Y., Hottinger, A., Hegi, M.E., Kirson, E., Lavy-Shahaf, G., Ram, Z.

Volltext

Tumor Treating Fields (TTFields) – A novel cancer treatment modality: Translating preclinical evidence and engineering into a survival benefit with delayed decline in quality of li... von Stupp, R., Taphoorn, M., Dirven, L., Taillibert, S., Honnorat, J., Chen, T., Sroubek, J., Paek, S.H., Bruna Escuder, J., Easaw, J., David, C., Kim, C.Y., Desai, R., Kew, Y., Olivi, A., Hottinger, A., Kirson, E.D., Lavy-Shahaf, G., Hegi, M.E., Ram, Z.

Volltext

116 INVITED Targeted therapies and anti-angiogenic treatments in newly diagnosed malignant glioma von Stupp, R, van den Bent, M.J, Mirimanoff, R.O, Brandes, A.A, Hegi, M.E, Weller, M

Volltext

114 INVITED Malignant glioma: molecular pathways, mechanisms of disease and resistance to chemoradiotherapy von Hegi, M.E, Migliavacca, E, Gorlia, T, Lambiv, W.L, Shay, T, Domany, E, Delorenzi, M, Stupp, R, Murat, A

Volltext

Brain tumors: molecular biology and targeted therapies von Hegi, M.E., Murat, A., Lambiv, W.L., Stupp, R.

Volltext

24 Molecular profiles of gliomas, mechanistic insights and associations with outcome von Murat, A., Migliavacca, E., Shay, T., Stupp, R., Domany, E., Delorenzi, M., Hegi, M.E.

Volltext

DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients von Bady, P., Marosi, C., Weller, M., Gronberg, B.H., Schultz, H., Taphoorn, M.J.B., Gijtenbeek, J.M.M., Bent, M.J. van den, Deimling, A. von, Stupp, R., Malmstrom, A., Hegi, M.E.

Volltext bestellen

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood von Weller, M., Bent, M. van den, Preusser, M., Rhun, E. le, Tonn, J.C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., French, P., Hegi, M.E., Jakola, A.S., Platten, M., Roth, P., Ruda, R., Short, S., Smits, M., Taphoorn, M.J.B., Deimling, A. von, Westphal, M., Soffietti, R., Reifenberger, G., Wick, W.

Volltext bestellen

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions von Wen, P.Y., Weller, M., Lee, E.Q., Alexander, B.M., Barnholtz-Sloan, J.S., Barthel, F.P., Batchelor, T.T., Bindra, R.S., Chang, S.M., Chiocca, E.A., Cloughesy, T.F., DeGroot, J.F., Galanis, E., Gilbert, M.R., Hegi, M.E., Horbinski, C., Huang, R.Y., Lassman, A.B., Rhun, E. le, Lim, M., Mehta, M.P., Mellinghoff, I.K., Minniti, G., Nathanson, D., Platten, M., Preusser, M., Roth, P., Sanson, M., Schiff, D., Short, S.C., Taphoorn, M.J.B., Tonn, J.C., Tsang, J., Verhaak, R.G.W., Deimling, A. von, Wick, W., Zadeh, G., Reardon, D.A., Aldape, K.D., Bent, M.J. van den

Volltext bestellen

Detection by 32P-postlabeling of thymidine glycol in gamma-irradiated DNA von Hegi, M.E

Volltext bestellen

No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet von Hegi, M.E., Ulrich, D., Sagelsdorff, P., Richter, C., Lutz, W.K.

Volltext

Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease von Papassotiropoulos, Andreas, Lambert, Jean-Charles, Wavrant-De Vrièze, Fabienne, Wollmer, M. Axel, von der Kammer, Heinz, Streffer, Johannes R., Maddalena, Alessia, Huynh, Kim-Dung, Wolleb, Sibylle, Lütjohann, Dieter, Schneider, Brigitte, Thal, Dietmar R., Grimaldi, Luigi M.E., Tsolaki, Magdalini, Kapaki, Elisabeth, Ravid, Rivka, Konietzko, Uwe, Hegi, Thomas, Pasch, Thomas, Jung, Hans, Braak, Heiko, Amouyel, Philippe, Rogaev, Evgeny I., Hardy, John, Hock, Christoph, Nitsch, Roger M.

Volltext

Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor of metalloproteinases 1 in sporadic Alzheimer's disease von Wollmer, M Axel, Papassotiropoulos, Andreas, Streffer, Johannes R, Grimaldi, Luigi M E, Kapaki, Elisabeth, Salani, Giuliana, Paraskevas, George P, Maddalena, Alessia, de Quervain, Dominique, Bieber, Claudia, Umbricht, Daniel, Lemke, Ulrike, Bosshardt, Simone, Degonda, Nadia, Henke, Katharina, Hegi, Thomas, Jung, Hans H, Pasch, Thomas, Hock, Christoph, Nitsch, Roger M

Volltext